GMP Certified / Diclofenac Sodium Injection 75mg/3ml

• Quality Standard: Bp, USP
• Ctd Dossier: Ready
• Documentation: Copp, COA
• Factory Certification: GMP
• Transport Package: Carton
• Specification: 75mg/3ml
• Model NO.: injection
• Trademark: Sinolead
• Origin: China
• Production Capacity: 100, 000, 000 Per Year

Product Description

Product Description

Generic Name	Diclofenac Sodium Injection
Strength	75mg/3ml
Packing	2*5 amps/box
Origin	China

Value-added services:
 Packaging design by our team
 Registration service by our team
 Registration dossier available by our team
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Product name:
Diclofenac Sodium Injection

Character:
This product is almost colorless clear liquid.

Indications:
1. It is used to relieve the symptoms of joint swelling and pain during acute attacks of rheumatoid arthritis, osteoarthritis, spondyloarthropathy, gouty arthritis, rheumatoid arthritis and other chronic arthritis.
2. Relieve various soft tissue acute rheumatic pain, such as shoulder pain, tenosynovitis, bursitis, myalgia, etc.
3. Acute mild and moderate pain such as injury pain, primary dysmenorrhea, toothache, headache, etc., after surgery, after trauma, after strain and after exercise.
4. It has antipyretic effect on fever in adults and children.

Adverse reactions:
1. There are common gastrointestinal reactions, such as stomach discomfort, burning, acid reflux, poor appetite, nausea, etc., which can disappear by stopping the drug or symptomatic treatment. Long-term application can cause gastric ulcer, gastric bleeding, gastric perforation.
2. A small number of edema, oliguria, electrolyte disorders and so on.
3. Occasional neurological reactions (incidence [1%]), such as headache, dizziness, drowsiness, excitement, etc.
4. Swelling and pain at the injection site.

Pharmacological action:
1. Alcohol consumption or use with other NSaids increases gastrointestinal adverse reactions and the risk of ulcers. Long-term use with acetaminophen can increase the toxic side effects on the kidney.
2. When used with aspirin or other salicylic acid drugs, the efficacy is not enhanced, but the incidence of gastrointestinal adverse reactions and bleeding tendency is increased.
3. When used with heparin, dicoumarin and other anticoagulants and platelet aggregation inhibitors, the risk of bleeding is increased.
4. When used with furosemide, the sodium excretion and antihypertensive effects of the latter were reduced.
5. When used with verapamil and nitrophenidine, the blood concentration of this product increases.
6. This product can increase the blood concentration of digoxin, the same time should pay attention to adjust the dose of digoxin.
Seven. When used together with antihypertensive drugs, the antihypertensive effect of the latter can be affected.
8. Prosulfa can reduce the excretion of this product, increase the blood concentration, thereby increasing toxicity, so the dose of this product should be reduced when used together.
9. This product can reduce the excretion of methotrexate, increase its blood concentration, and even reach toxic levels, so this product should not be used with medium or large doses of methotrexate.
10. This product can reduce the effect of insulin and other hypoglycemic agents, and increase blood sugar.
11. When used together with potassium-conserving diuretics, hyperkalemia can be caused.
12. Aspirin can reduce the bioavailability of this product.

Storage:
Keep out of light and tightly sealed.